title: [Second tumors in patients treated for Hodgkin's disease].
authors.forename: P
authors.initials: P
authors.lastname: España
authors.forename: F
authors.initials: F
authors.lastname: Bonilla
authors.forename: M
authors.initials: M
authors.lastname: Yebra
authors.forename: J
authors.initials: J
authors.lastname: Diego
authors.forename: M
authors.initials: M
authors.lastname: Alvarez de Mon
authors.forename: M
authors.initials: M
authors.lastname: Marazuela
authors.forename: A
authors.initials: A
authors.lastname: Durántez
mesh_terms: D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000209:etiology*; D003131:Combined Modality Therapy; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D006801:Humans; D007938:Leukemia / Q000209:etiology*; D008175:Lung Neoplasms / Q000209:etiology*; D008228:Lymphoma, Non-Hodgkin / Q000209:etiology*; D008297:Male; D008466:Mechlorethamine / Q000008:administration & dosage; D008875:Middle Aged; D009378:Neoplasms, Multiple Primary; D011241:Prednisone / Q000008:administration & dosage; D011344:Procarbazine / Q000008:administration & dosage; D013997:Time Factors; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D011344:Procarbazine; D008466:Mechlorethamine; D014750:Vincristine; D011241:Prednisone
vernacular_title: Segundos tumores en enfermos tratados por enfermedad de Hodgkin.